576 related articles for article (PubMed ID: 33128875)
1. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
Shu T; Ning W; Wu D; Xu J; Han Q; Huang M; Zou X; Yang Q; Yuan Y; Bie Y; Pan S; Mu J; Han Y; Yang X; Zhou H; Li R; Ren Y; Chen X; Yao S; Qiu Y; Zhang DY; Xue Y; Shang Y; Zhou X
Immunity; 2020 Nov; 53(5):1108-1122.e5. PubMed ID: 33128875
[TBL] [Abstract][Full Text] [Related]
2. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
Messner CB; Demichev V; Wendisch D; Michalick L; White M; Freiwald A; Textoris-Taube K; Vernardis SI; Egger AS; Kreidl M; Ludwig D; Kilian C; Agostini F; Zelezniak A; Thibeault C; Pfeiffer M; Hippenstiel S; Hocke A; von Kalle C; Campbell A; Hayward C; Porteous DJ; Marioni RE; Langenberg C; Lilley KS; Kuebler WM; Mülleder M; Drosten C; Suttorp N; Witzenrath M; Kurth F; Sander LE; Ralser M
Cell Syst; 2020 Jul; 11(1):11-24.e4. PubMed ID: 32619549
[TBL] [Abstract][Full Text] [Related]
3. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
Barberis E; Timo S; Amede E; Vanella VV; Puricelli C; Cappellano G; Raineri D; Cittone MG; Rizzi E; Pedrinelli AR; Vassia V; Casciaro FG; Priora S; Nerici I; Galbiati A; Hayden E; Falasca M; Vaschetto R; Sainaghi PP; Dianzani U; Rolla R; Chiocchetti A; Baldanzi G; Marengo E; Manfredi M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207699
[TBL] [Abstract][Full Text] [Related]
4. Classification criteria for the deceased referred for forensic post-mortem examinations with regard to epidemiological risk posed by SARS CoV-2/COVID-19 during the pandemic.
Jurek T; Teresiński G
Arch Med Sadowej Kryminol; 2019; 69(4):158-163. PubMed ID: 32564574
[No Abstract] [Full Text] [Related]
5. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.
Whetton AD; Preston GW; Abubeker S; Geifman N
J Proteome Res; 2020 Nov; 19(11):4219-4232. PubMed ID: 32657586
[TBL] [Abstract][Full Text] [Related]
6. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).
Ciaccio M; Agnello L
Diagnosis (Berl); 2020 Nov; 7(4):365-372. PubMed ID: 32589600
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
8. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
10. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.
Song JW; Lam SM; Fan X; Cao WJ; Wang SY; Tian H; Chua GH; Zhang C; Meng FP; Xu Z; Fu JL; Huang L; Xia P; Yang T; Zhang S; Li B; Jiang TJ; Wang R; Wang Z; Shi M; Zhang JY; Wang FS; Shui G
Cell Metab; 2020 Aug; 32(2):188-202.e5. PubMed ID: 32610096
[TBL] [Abstract][Full Text] [Related]
11. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
[TBL] [Abstract][Full Text] [Related]
12. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
[No Abstract] [Full Text] [Related]
13. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.
Li L; Tong X; Chen H; He R; Lv Q; Yang R; Zhao L; Wang J; Xu H; Liu C; Chen G; Chen S; Li C; Qiao J; Yang J; Wu Y; Liu Z
Transfusion; 2020 Aug; 60(8):1765-1772. PubMed ID: 32627216
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 viral load is associated with increased disease severity and mortality.
Fajnzylber J; Regan J; Coxen K; Corry H; Wong C; Rosenthal A; Worrall D; Giguel F; Piechocka-Trocha A; Atyeo C; Fischinger S; Chan A; Flaherty KT; Hall K; Dougan M; Ryan ET; Gillespie E; Chishti R; Li Y; Jilg N; Hanidziar D; Baron RM; Baden L; Tsibris AM; Armstrong KA; Kuritzkes DR; Alter G; Walker BD; Yu X; Li JZ;
Nat Commun; 2020 Oct; 11(1):5493. PubMed ID: 33127906
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
Wallentin L; Lindbäck J; Eriksson N; Hijazi Z; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Oldgren J; Siegbahn A
Eur Heart J; 2020 Nov; 41(41):4037-4046. PubMed ID: 32984892
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers associated with COVID-19 disease progression.
Ponti G; Maccaferri M; Ruini C; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):389-399. PubMed ID: 32503382
[TBL] [Abstract][Full Text] [Related]
18. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
Song JW; Zhang C; Fan X; Meng FP; Xu Z; Xia P; Cao WJ; Yang T; Dai XP; Wang SY; Xu RN; Jiang TJ; Li WG; Zhang DW; Zhao P; Shi M; Agrati C; Ippolito G; Maeurer M; Zumla A; Wang FS; Zhang JY
Nat Commun; 2020 Jul; 11(1):3410. PubMed ID: 32641700
[TBL] [Abstract][Full Text] [Related]
19. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients.
Marcello A; Civra A; Milan Bonotto R; Nascimento Alves L; Rajasekharan S; Giacobone C; Caccia C; Cavalli R; Adami M; Brambilla P; Lembo D; Poli G; Leoni V
Redox Biol; 2020 Sep; 36():101682. PubMed ID: 32810737
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
Shen B; Yi X; Sun Y; Bi X; Du J; Zhang C; Quan S; Zhang F; Sun R; Qian L; Ge W; Liu W; Liang S; Chen H; Zhang Y; Li J; Xu J; He Z; Chen B; Wang J; Yan H; Zheng Y; Wang D; Zhu J; Kong Z; Kang Z; Liang X; Ding X; Ruan G; Xiang N; Cai X; Gao H; Li L; Li S; Xiao Q; Lu T; Zhu Y; Liu H; Chen H; Guo T
Cell; 2020 Jul; 182(1):59-72.e15. PubMed ID: 32492406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
